表紙
市場調查報告書
商品編碼
648650

腎臟結石管理市場:產業分析,各地區的預測,應用可能性,競爭市場佔有率,預測

Kidney Stones Management Market Size By Type, By Diagnostics, By Treatment, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 - 2025

出版日期: | 出版商: Global Market Insights Inc. | 英文 135 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球腎臟結石管理市場相關調查分析,提供產業的考察,各市場區隔的市場分析,各地區分析,主要企業等系統性資訊。

第1章 調查手法

第2章 摘要整理

第3章 腎臟結石管理產業的考察

  • 產業區分
  • 產業形勢
  • 產業生態系統
  • 通路分析
  • 產業影響力
  • 成長可能性分析
  • 法規形勢
  • 波特的五力分析
  • 企業形勢
  • PESTEL分析

第4章 腎臟結石管理市場:各類型

  • 主要市場區隔趨勢
  • 草酸鈣
  • 磷酸鈣
  • 尿酸
  • 鹿角狀結石
  • 半胱胺酸

第5章 腎臟結石管理市場:各診斷

  • 主要市場區隔趨勢
  • 腹部X光掃描
  • 電腦斷層掃描
  • 超音波
  • 腹部MRI
  • IVP
  • 其他

第6章 腎臟結石管理市場:不同治療

  • 主要市場區隔趨勢
  • 體外震波結石碾碎 (ESWL/SWL)
  • 雷射碎石/尿道鏡
  • 經皮腎結石摘出 (PNL)
  • 其他

第7章 腎臟結石管理市場:各地區

  • 主要市場區隔趨勢
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第8章 企業簡介

  • Allengers Medical Systems Ltd.
  • Boston Scientific Corporation
  • C.R. Bard, Inc.
  • Karl Storz GmbH & Co. KG
  • Cook Medical
  • Coloplast Group
  • DirexGroup
  • Dornier MedTech
  • Olympus Corporation
  • Richard Wolf GmbH
  • EDAP TMS SA
  • Elmed Medical Systems
  • Siemens Healthcare
  • Medispec Ltd.
目錄
Product Code: 2603

Title:
Kidney Stones Management Market Size By Type (Calcium Oxalate, Calcium Phosphate, Uric Acid, Struvite, Cysteine), By Diagnostics (Abdominal X-ray, Computed Tomography, Ultrasound, Abdominal MRI, Intravenous Pyelography), By Treatment (Extracorporeal shock wave lithotripsy, Ureteroscopy, Percutaneous Nephrolithotomy), Industry Analysis Report, Regional Outlook (U.S., Canada, UK, Germany, France, Italy, Spain, Russia, China, Japan, India, South Korea, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE), Application Potential, Competitive Market Share & Forecast, 2019 - 2025 .

Kidney Stones Management Market is expected to exceed USD 2 billion by 2025.

Some major findings of the kidney stones management market report include:

  • Changing lifestyle and increasing levels of protein, oxalate, sodium or sugar in diet will serve as a high impact rendering factor for kidney stones management market growth
  • Technological advancement in devices along with inclination towards minimally invasive techniques will ensure quicker patient recovery and offer better healthcare outcomes
  • Government initiatives and favorable reimbursement scenario for kidney stones treatment will prove beneficial for the industry progress
  • Major players operating in the kidney stones management market include Boston Scientific, Cook Medical, Dornier MedTech, Coloplast, etc.
  • Competitors focus on offering advanced solutions to capitalize on market opportunities and gain competitive edge over others

Increasing prevalence and recurrence rate of kidney stones across the globe will prove beneficial for industry growth in the near future. Kidney stones occur as a result of crystal formation within kidneys. These crystals are caused due to several physicochemical events including nucleation, supersaturation, growth, retention of urinary stone constituents and aggregation within tubular cells. Moreover, recurrence of kidney stones is a serious issue that is difficult to prevent. Thus, growing number of patients suffering from kidney stones and recurring rate of the disease will require superior quality diagnosis and treatment thereby, favoring business expansion in the foreseeable future.

Growing awareness among people regarding overall kidney health will serve to be another impact rendering factor in the business growth. Numerous initiatives undertaken by government and industry players to create awareness regarding prevention of chronic kidney disorders will benefit the market development. Moreover, advantages associated with early diagnosis of kidney stones and timely treatment will create higher demand for nephrolithiasis management in healthcare facilities, thereby propelling business growth over the forecast period.

Kidney stones are bifurcated into calcium oxalate, calcium phosphate, uric acid, struvite and cysteine stones. Struvite segment of kidney stones management market accounted for more than USD 150 million in 2018 and will witness significant growth during the analysis timeframe. Struvite is a crystalline substance composed of magnesium ammonium phosphate, also termed as triple phosphate and infection stones. Struvite stones are diagnosed by doctors using X-ray, computed tomography or MRI machines. Extracorporeal shock wave lithotripsy (ESWL) is the most widely used treatment that efficiently pulverizes infected renal calculi. Less intake of fluid leading to formation of calcium and phosphate crystals should further favor struvite stones segmental growth.

Diagnostics segment is classified into abdominal X-ray, computed tomography, ultrasound, abdominal MRI, intravenous pyelography and others. Ultrasound segment held around 20% revenue share in 2018 and is poised to show tremendous growth during the forthcoming years. Ultrasound is a non-invasive diagnostic tool that uses transducer to assess severity of the disorder. Ultrasound emits no radiation and is performed without any complexities. Thus, patient's comfort coupled with elimination of harmful radiations will raise patient preference towards ultrasound, thereby augmenting segmental revenue.

Treatment segment is bifurcated into extracorporeal shock wave lithotripsy, ureteroscopy, percutaneous nephrolithotomy and others. Percutaneous nephrolithotomy segment is anticipated to witness over 4% CAGR during the analysis timeframe. Percutaneous nephrolithotomy process involves making incision in the back to remove kidney stones. Moreover, it is often used for removal of large and odd shaped stones that cannot be treated with ESWL or ureteroscopy. Advantages of PCNL technique including minimally invasive nature leading to shorter hospital stay and significantly shorter recovery time will escalate segmental growth during the analysis period.

Japan kidney stones management market was valued over USD 95 million in 2018 and is projected to witness similar growth trend over the forecast timeframe. Demographic trends such as increasing geriatric population suffering from kidney disorders along with significant healthcare expenditure will surge demand for superior quality treatment. Moreover, unhealthy intake of dietary supplements and favorable reimbursement scenario will further foster nephrolithiasis management business expansion in the country.

Few notable companies operating in kidney stones management market include Cook Medical LLC, Allengers Medical Systems, DirexGroup, Elmed Medical Systems, Coloplast, Dornier MedTech, C. R. Bard, Medispec and Boston Scientific. Industry players are implementing numerous strategies to develop efficient products and gain a competitive edge over its rivals. For instance, in April 2019, Dornier MedTech launched AXIS, a single-use digital flexible ureteroscope as well as stone management products in the U.S. The new product launch will help the company to garner higher market share and broaden existing customer base.

Table of Contents

Chapter 1. Methodology

  • 1.1. Methodology
  • 1.2. Market definitions
  • 1.3. Forecast parameters
  • 1.4. Data sources
    • 1.4.1. Secondary
      • 1.4.1.1. Paid sources
      • 1.4.1.2. Unpaid sources
    • 1.4.2. Primary

Chapter 2. Executive Summary

  • 2.1. Kidney stones management industry 360 degree synopsis, 2014 - 2025
    • 2.1.1. Business trends
    • 2.1.2. Type trends
    • 2.1.3. Diagnostics trends
    • 2.1.4. Treatment trends
    • 2.1.5. Regional trends

Chapter 3. Kidney Stones Management Industry Insights

  • 3.1. Industry segmentation
  • 3.2. Industry landscape, 2014 - 2025 (USD Million)
  • 3.3. Industry impact forces
    • 3.3.1. Growth drivers
      • 3.3.1.1. Increasing prevalence and recurrence rate of kidney stones globally
      • 3.3.1.2. Advancements in ureteroscopy technique
      • 3.3.1.3. Favorable reimbursement for lithotripsy procedures
      • 3.3.1.4. Inclination towards undergoing minimally invasive surgeries
      • 3.3.1.5. Rising awareness regarding overall kidney health
    • 3.3.2. Industry pitfalls & challenges
      • 3.3.2.1. Lack of treatment awareness in certain countries
      • 3.3.2.2. Potential long-term adverse effects of lithotripsy
  • 3.4. Regulatory landscape
  • 3.5. 3.4.1. Growth potential analysis
    • 3.5.1. By type
    • 3.5.2. By diagnostics
    • 3.5.3. By treatment
  • 3.6. Porter's analysis
  • 3.7. Competitive landscape, 2018
    • 3.7.1. Strategy dashboard
  • 3.8. PESTEL analysis

Chapter 4. Kidney Stones Management Market, By Type

  • 4.1. Key segment trends
  • 4.2. Calcium oxalate
    • 4.2.1. Market size, by region, 2014 - 2025 (USD Million)
  • 4.3. Calcium phosphate
    • 4.3.1. Market size, by region, 2014 - 2025 (USD Million)
  • 4.4. Uric acid
    • 4.4.1. Market size, by region, 2014 - 2025 (USD Million)
  • 4.5. Struvite
    • 4.5.1. Market size, by region, 2014 - 2025 (USD Million)
  • 4.6. Cysteine
    • 4.6.1. Market size, by region, 2014 - 2025 (USD Million)

Chapter 5. Kidney Stones Management Market, By Diagnostics

  • 5.1. Key segment trends
  • 5.2. Abdominal X-ray
    • 5.2.1. Market size, by region, 2014 - 2025 (USD Million)
  • 5.3. Computed tomography
    • 5.3.1. Market size, by region, 2014 - 2025 (USD Million)
  • 5.4. Ultrasound
    • 5.4.1. Market size, by region, 2014 - 2025 (USD Million)
  • 5.5. Abdominal MRI
    • 5.5.1. Market size, by region, 2014 - 2025 (USD Million)
  • 5.6. Intravenous pyelography
    • 5.6.1. Market size, by region, 2014 - 2025 (USD Million)
  • 5.7. Others
    • 5.7.1. Market size, by region, 2014 - 2025 (USD Million)

Chapter 6. Kidney Stones Management Market, By Treatment

  • 6.1. Key segment trends
  • 6.2. Extracorporeal Shock Wave Lithotripsy (ESWL)
    • 6.2.1. Market size, by region, 2014 - 2025 (USD Million)
  • 6.3. Ureteroscopy
    • 6.3.1. Market size, by region, 2014 - 2025 (USD Million)
  • 6.4. Percutaneous Nephrolithotomy (PCNL)
    • 6.4.1. Market size, by region, 2014 - 2025 (USD Million)
  • 6.5. Others
    • 6.5.1. Market size, by region, 2014 - 2025 (USD Million)

Chapter 7. Kidney Stones Management Market, By Region

  • 7.1. Key regional trends
  • 7.2. North America
    • 7.2.1. Market size, by country, 2014 - 2025 (USD Million)
    • 7.2.2. Market size, by type, 2014 - 2025 (USD Million)
    • 7.2.3. Market size, by diagnostics, 2014 - 2025 (USD Million)
    • 7.2.4. Market size, by treatment, 2014 - 2025 (USD Million)
    • 7.2.5. U.S.
      • 7.2.5.1. Market size, by type, 2014 - 2025 (USD Million)
      • 7.2.5.2. Market size, by diagnostics, 2014 - 2025 (USD Million)
      • 7.2.5.3. Market size, by treatment, 2014 - 2025 (USD Million)
    • 7.2.6. Canada
      • 7.2.6.1. Market size, by type, 2014 - 2025 (USD Million)
      • 7.2.6.2. Market size, by diagnostics, 2014 - 2025 (USD Million)
    • 7.2.7. Market size, by treatment, 2014 - 2025 (USD Million)
  • 7.3. Europe
    • 7.3.1. Market size, by country, 2014 - 2025 (USD Million)
    • 7.3.2. Market size, by type, 2014 - 2025 (USD Million)
    • 7.3.3. Market size, by diagnostics, 2014 - 2025 (USD Million)
    • 7.3.4. Market size, by treatment, 2014 - 2025 (USD Million)
    • 7.3.5. UK
      • 7.3.5.1. Market size, by type, 2014 - 2025 (USD Million)
      • 7.3.5.2. Market size, by diagnostics, 2014 - 2025 (USD Million)
      • 7.3.5.3. Market size, by treatment, 2014 - 2025 (USD Million)
    • 7.3.6. Germany
      • 7.3.6.1. Market size, by type, 2014 - 2025 (USD Million)
      • 7.3.6.2. Market size, by diagnostics, 2014 - 2025 (USD Million)
      • 7.3.6.3. Market size, by treatment, 2014 - 2025 (USD Million)
    • 7.3.7. France
      • 7.3.7.1. Market size, by type, 2014 - 2025 (USD Million)
      • 7.3.7.2. Market size, by diagnostics, 2014 - 2025 (USD Million)
      • 7.3.7.3. Market size, by treatment, 2014 - 2025 (USD Million)
    • 7.3.8. Italy
      • 7.3.8.1. Market size, by type, 2014 - 2025 (USD Million)
      • 7.3.8.2. Market size, by diagnostics, 2014 - 2025 (USD Million)
      • 7.3.8.3. Market size, by treatment, 2014 - 2025 (USD Million)
    • 7.3.9. Spain
      • 7.3.9.1. Market size, by type, 2014 - 2025 (USD Million)
      • 7.3.9.2. Market size, by diagnostics, 2014 - 2025 (USD Million)
      • 7.3.9.3. Market size, by treatment, 2014 - 2025 (USD Million)
    • 7.3.10. Russia
      • 7.3.10.1. Market size, by type, 2014 - 2025 (USD Million)
      • 7.3.10.2. Market size, by diagnostics, 2014 - 2025 (USD Million)
      • 7.3.10.3. Market size, by treatment, 2014 - 2025 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Market size, by country, 2014 - 2025 (USD Million)
    • 7.4.2. Market size, by type, 2014 - 2025 (USD Million)
    • 7.4.3. Market size, by diagnostics, 2014 - 2025 (USD Million)
    • 7.4.4. Market size, by treatment, 2014 - 2025 (USD Million)
    • 7.4.5. Japan
      • 7.4.5.1. Market size, by type, 2014 - 2025 (USD Million)
      • 7.4.5.2. Market size, by diagnostics, 2014 - 2025 (USD Million)
      • 7.4.5.3. Market size, by treatment, 2014 - 2025 (USD Million)
    • 7.4.6. China
      • 7.4.6.1. Market size, by type, 2014 - 2025 (USD Million)
      • 7.4.6.2. Market size, by diagnostics, 2014 - 2025 (USD Million)
      • 7.4.6.3. Market size, by treatment, 2014 - 2025 (USD Million)
    • 7.4.7. India
      • 7.4.7.1. Market size, by type, 2014 - 2025 (USD Million)
      • 7.4.7.2. Market size, by diagnostics, 2014 - 2025 (USD Million)
      • 7.4.7.3. Market size, by treatment, 2014 - 2025 (USD Million)
    • 7.4.8. South Korea
      • 7.4.8.1. Market size, by type, 2014 - 2025 (USD Million)
      • 7.4.8.2. Market size, by diagnostics, 2014 - 2025 (USD Million)
      • 7.4.8.3. Market size, by treatment, 2014 - 2025 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Market size, by country, 2014 - 2025 (USD Million)
    • 7.5.2. Market size, by type, 2014 - 2025 (USD Million)
    • 7.5.3. Market size, by diagnostics, 2014 - 2025 (USD Million)
    • 7.5.4. Market size, by treatment, 2014 - 2025 (USD Million)
    • 7.5.5. Brazil
      • 7.5.5.1. Market size, by type, 2014 - 2025 (USD Million)
      • 7.5.5.2. Market size, by diagnostics, 2014 - 2025 (USD Million)
      • 7.5.5.3. Market size, by treatment, 2014 - 2025 (USD Million)
    • 7.5.6. Mexico
      • 7.5.6.1. Market size, by type, 2014 - 2025 (USD Million)
      • 7.5.6.2. Market size, by diagnostics, 2014 - 2025 (USD Million)
      • 7.5.6.3. Market size, by treatment, 2014 - 2025 (USD Million)
    • 7.5.7. Argentina
      • 7.5.7.1. Market size, by type, 2014 - 2025 (USD Million)
      • 7.5.7.2. Market size, by diagnostics, 2014 - 2025 (USD Million)
      • 7.5.7.3. Market size, by treatment, 2014 - 2025 (USD Million)
  • 7.6. MEA
    • 7.6.1. Market size, by country, 2014 - 2025 (USD Million)
    • 7.6.2. Market size, by type, 2014 - 2025 (USD Million)
    • 7.6.3. Market size, by diagnostics, 2014 - 2025 (USD Million)
    • 7.6.4. Market size, by treatment, 2014 - 2025 (USD Million)
    • 7.6.5. South Africa
      • 7.6.5.1. Market size, by type, 2014 - 2025 (USD Million)
      • 7.6.5.2. Market size, by diagnostics, 2014 - 2025 (USD Million)
      • 7.6.5.3. Market size, by treatment, 2014 - 2025 (USD Million)
    • 7.6.6. Saudi Arabia
      • 7.6.6.1. Market size, by type, 2014 - 2025 (USD Million)
      • 7.6.6.2. Market size, by diagnostics, 2014 - 2025 (USD Million)
      • 7.6.6.3. Market size, by treatment, 2014 - 2025 (USD Million)
    • 7.6.7. UAE
      • 7.6.7.1. Market size, by type, 2014 - 2025 (USD Million)
      • 7.6.7.2. Market size, by diagnostics, 2014 - 2025 (USD Million)
      • 7.6.7.3. Market size, by treatment, 2014 - 2025 (USD Million)

Chapter 8. Company Profiles

  • 8.1. Allengers Medical Systems Ltd
    • 8.1.1. Business overview
    • 8.1.2. Financial data
    • 8.1.3. Product type landscape
    • 8.1.4. Strategic outlook
    • 8.1.5. SWOT analysis
  • 8.2. Boston Scientific Corporation
    • 8.2.1. Business overview
    • 8.2.2. Financial data
    • 8.2.3. Product type landscape
    • 8.2.4. Strategic outlook
    • 8.2.5. SWOT analysis
  • 8.3. Coloplast A/S
    • 8.3.1. Business overview
    • 8.3.2. Financial data
    • 8.3.3. Product type landscape
    • 8.3.4. Strategic outlook
    • 8.3.5. SWOT analysis
  • 8.4. Cook Medical LLC
    • 8.4.1. Business overview
    • 8.4.2. Financial data
    • 8.4.3. Product type landscape
    • 8.4.4. Strategic outlook
    • 8.4.5. SWOT analysis
  • 8.5. C. R. Bard, Inc
    • 8.5.1. Business overview
    • 8.5.2. Financial data
    • 8.5.3. Product type landscape
    • 8.5.4. Strategic outlook
    • 8.5.5. SWOT analysis
  • 8.6. DirexGroup
    • 8.6.1. Business overview
    • 8.6.2. Financial data
    • 8.6.3. Product type landscape
    • 8.6.4. Strategic outlook
    • 8.6.5. SWOT analysis
  • 8.7. Dornier MedTech
    • 8.7.1. Business overview
    • 8.7.2. Financial data
    • 8.7.3. Product type landscape
    • 8.7.4. Strategic outlook
    • 8.7.5. SWOT analysis
  • 8.8. EDAP TMS S.A
    • 8.8.1. Business overview
    • 8.8.2. Financial data
    • 8.8.3. Product type landscape
    • 8.8.4. Strategic outlook
    • 8.8.5. SWOT analysis
  • 8.9. Elmed Medical Systems
    • 8.9.1. Business overview
    • 8.9.2. Financial data
    • 8.9.3. Product type landscape
    • 8.9.4. Strategic outlook
    • 8.9.5. SWOT analysis
  • 8.10. Karl Storz GmbH
    • 8.10.1. Business overview
    • 8.10.2. Financial data
    • 8.10.3. Product type landscape
    • 8.10.4. Strategic outlook
    • 8.10.5. SWOT analysis
  • 8.11. Medispec Ltd
    • 8.11.1. Business overview
    • 8.11.2. Financial data
    • 8.11.3. Product type landscape
    • 8.11.4. Strategic outlook
    • 8.11.5. SWOT analysis
  • 8.12. Olympus Corporation
    • 8.12.1. Business overview
    • 8.12.2. Financial data
    • 8.12.3. Product type landscape
    • 8.12.4. Strategic outlook
    • 8.12.5. SWOT analysis
  • 8.13. Richard Wolf GmbH
    • 8.13.1. Business overview
    • 8.13.2. Financial data
    • 8.13.3. Product type landscape
    • 8.13.4. Strategic outlook
    • 8.13.5. SWOT analysis
  • 8.14. Siemens Healthineers
    • 8.14.1. Business overview
    • 8.14.2. Financial data
    • 8.14.3. Product type landscape
    • 8.14.4. Strategic outlook
    • 8.14.5. SWOT analysis

Data Tables

  • TABLE 1. Kidney stones management industry 360 degree synopsis, 2014 - 2025
  • TABLE 2. Global kidney stones management market, 2014 - 2025 (USD Million)
  • TABLE 3. Global kidney stones management market, by type, 2014 - 2025 (USD Million)
  • TABLE 4. Global kidney stones management market, by diagnostics, 2014 - 2025 (USD Million)
  • TABLE 5. Global kidney stones management market, by treatment, 2014 - 2025 (USD Million)
  • TABLE 6. Global kidney stones management market, by region, 2014 - 2025 (USD Million)
  • TABLE 7. Industry impact forces
  • TABLE 8. Calcium oxalate market size, by region, 2014 - 2025 (USD Million)
  • TABLE 9. Calcium phosphate market size, by region, 2014 - 2025 (USD Million)
  • TABLE 10. Uric acid market size, by region, 2014 - 2025 (USD Million)
  • TABLE 11. Struvite market size, by region, 2014 - 2025 (USD Million)
  • TABLE 12. Cysteine market size, by region, 2014 - 2025 (USD Million)
  • TABLE 13. Abdominal X-ray market size, by region, 2014 - 2025 (USD Million)
  • TABLE 14. Computed tomography market size, by region, 2014 - 2025 (USD Million)
  • TABLE 15. Ultrasound market size, by region, 2014 - 2025 (USD Million)
  • TABLE 16. Abdominal MRI market size, by region, 2014 - 2025 (USD Million)
  • TABLE 17. Intravenous pyelography market size, by region, 2014 - 2025 (USD Million)
  • TABLE 18. Others market size, by region, 2014 - 2025 (USD Million)
  • TABLE 19. ESWL market size, by region, 2014 - 2025 (USD Million)
  • TABLE 20. Ureteroscopy market size, by region, 2014 - 2025 (USD Million)
  • TABLE 21. PCNL market size, by region, 2014 - 2025 (USD Million)
  • TABLE 22. Others market size, by region, 2014 - 2025 (USD Million)
  • TABLE 23. North America kidney stones management market size, by country, 2014 - 2025 (USD Million)
  • TABLE 24. North America kidney stones management market size, by type, 2014 - 2025 (USD Million)
  • TABLE 25. North America kidney stones management market size, by diagnostics, 2014 - 2025 (USD Million)
  • TABLE 26. North America kidney stones management market size, by treatment, 2014 - 2025 (USD Million)
  • TABLE 27. U.S. kidney stones management market size, by type, 2014 - 2025 (USD Million)
  • TABLE 28. U.S. kidney stones management market size, by diagnostics, 2014 - 2025 (USD Million)
  • TABLE 29. U.S. kidney stones management market size, by treatment, 2014 - 2025 (USD Million)
  • TABLE 30. Canada kidney stones management market size, by type, 2014 - 2025 (USD Million)
  • TABLE 31. Canada kidney stones management market size, by diagnostics, 2014 - 2025 (USD Million)
  • TABLE 32. Canada kidney stones management market size, by treatment, 2014 - 2025 (USD Million)
  • TABLE 33. Europe kidney stones management market size, by country, 2014 - 2025 (USD Million)
  • TABLE 34. Europe kidney stones management market size, by type, 2014 - 2025 (USD Million)
  • TABLE 35. Europe kidney stones management market size, by diagnostics, 2014 - 2025 (USD Million)
  • TABLE 36. Europe kidney stones management market size, by treatment, 2014 - 2025 (USD Million)
  • TABLE 37. Germany kidney stones management market size, by type, 2014 - 2025 (USD Million)
  • TABLE 38. Germany kidney stones management market size, by diagnostics, 2014 - 2025 (USD Million)
  • TABLE 39. Germany kidney stones management market size, by treatment, 2014 - 2025 (USD Million)
  • TABLE 40. UK kidney stones management market size, by type, 2014 - 2025 (USD Million)
  • TABLE 41. UK kidney stones management market size, by diagnostics, 2014 - 2025 (USD Million)
  • TABLE 42. UK kidney stones management market size, by treatment, 2014 - 2025 (USD Million)
  • TABLE 43. France kidney stones management market size, by type, 2014 - 2025 (USD Million)
  • TABLE 44. France kidney stones management market size, by diagnostics, 2014 - 2025 (USD Million)
  • TABLE 45. France kidney stones management market size, by treatment, 2014 - 2025 (USD Million)
  • TABLE 46. Italy kidney stones management market size, by type, 2014 - 2025 (USD Million)
  • TABLE 47. Italy kidney stones management market size, by diagnostics, 2014 - 2025 (USD Million)
  • TABLE 48. Italy kidney stones management market size, by treatment, 2014 - 2025 (USD Million)
  • TABLE 49. Spain kidney stones management market size, by type, 2014 - 2025 (USD Million)
  • TABLE 50. Spain kidney stones management market size, by diagnostics, 2014 - 2025 (USD Million)
  • TABLE 51. Spain kidney stones management market size, by treatment, 2014 - 2025 (USD Million)
  • TABLE 52. Russia kidney stones management market size, by type, 2014 - 2025 (USD Million)
  • TABLE 53. Russia kidney stones management market size, by diagnostics, 2014 - 2025 (USD Million)
  • TABLE 54. Russia kidney stones management market size, by treatment, 2014 - 2025 (USD Million)
  • TABLE 55. APAC kidney stones management market size, by country, 2014 - 2025 (USD Million)
  • TABLE 56. APAC kidney stones management market size, by type, 2014 - 2025 (USD Million)
  • TABLE 57. APAC kidney stones management market size, by diagnostics, 2014 - 2025 (USD Million)
  • TABLE 58. APAC kidney stones management market size, by treatment, 2014 - 2025 (USD Million)
  • TABLE 59. Japan kidney stones management market size, by type, 2014 - 2025 (USD Million)
  • TABLE 60. Japan kidney stones management market size, by diagnostics, 2014 - 2025 (USD Million)
  • TABLE 61. Japan kidney stones management market size, by treatment, 2014 - 2025 (USD Million)
  • TABLE 62. China kidney stones management market size, by type, 2014 - 2025 (USD Million)
  • TABLE 63. China kidney stones management market size, by diagnostics, 2014 - 2025 (USD Million)
  • TABLE 64. China kidney stones management market size, by treatment, 2014 - 2025 (USD Million)
  • TABLE 65. India kidney stones management market size, by type, 2014 - 2025 (USD Million)
  • TABLE 66. India kidney stones management market size, by diagnostics, 2014 - 2025 (USD Million)
  • TABLE 67. India kidney stones management market size, by treatment, 2014 - 2025 (USD Million)
  • TABLE 68. South Korea kidney stones management market size, by type, 2014 - 2025 (USD Million)
  • TABLE 69. South Korea kidney stones management market size, by diagnostics, 2014 - 2025 (USD Million)
  • TABLE 70. South Korea kidney stones management market size, by treatment, 2014 - 2025 (USD Million)
  • TABLE 71. LATAM kidney stones management market size, by country, 2014 - 2025 (USD Million)
  • TABLE 72. LATAM kidney stones management market size, by type, 2014 - 2025 (USD Million)
  • TABLE 73. LATAM kidney stones management market size, by diagnostics, 2014 - 2025 (USD Million)
  • TABLE 74. LATAM kidney stones management market size, by treatment, 2014 - 2025 (USD Million)
  • TABLE 75. Brazil kidney stones management market size, by type, 2014 - 2025 (USD Million)
  • TABLE 76. Brazil kidney stones management market size, by diagnostics, 2014 - 2025 (USD Million)
  • TABLE 77. Brazil kidney stones management market size, by treatment, 2014 - 2025 (USD Million)
  • TABLE 78. Mexico kidney stones management market size, by type, 2014 - 2025 (USD Million)
  • TABLE 79. Mexico kidney stones management market size, by diagnostics, 2014 - 2025 (USD Million)
  • TABLE 80. Mexico kidney stones management market size, by treatment, 2014 - 2025 (USD Million)
  • TABLE 81. Argentina kidney stones management market size, by type, 2014 - 2025 (USD Million)
  • TABLE 82. Argentina kidney stones management market size, by diagnostics, 2014 - 2025 (USD Million)
  • TABLE 83. Argentina kidney stones management market size, by treatment, 2014 - 2025 (USD Million)
  • TABLE 84. MEA kidney stones management market size, by country, 2014 - 2025 (USD Million)
  • TABLE 85. MEA kidney stones management market size, by type, 2014 - 2025 (USD Million)
  • TABLE 86. MEA kidney stones management market size, by diagnostics, 2014 - 2025 (USD Million)
  • TABLE 87. MEA kidney stones management market size, by treatment, 2014 - 2025 (USD Million)
  • TABLE 88. South Africa kidney stones management market size, by type, 2014 - 2025 (USD Million)
  • TABLE 89. South Africa kidney stones management market size, by diagnostics, 2014 - 2025 (USD Million)
  • TABLE 90. South Africa kidney stones management market size, by treatment, 2014 - 2025 (USD Million)
  • TABLE 91. Saudi Arabia kidney stones management market size, by type, 2014 - 2025 (USD Million)
  • TABLE 92. Saudi Arabia kidney stones management market size, by diagnostics, 2014 - 2025 (USD Million)
  • TABLE 93. Saudi Arabia kidney stones management market size, by treatment, 2014 - 2025 (USD Million)
  • TABLE 94. UAE kidney stones management market size, by type, 2014 - 2025 (USD Million)
  • TABLE 95. UAE kidney stones management market size, by diagnostics, 2014 - 2025 (USD Million)
  • TABLE 96. UAE kidney stones management market size, by treatment, 2014 - 2025 (USD Million)

Charts & Figures

  • FIG. 1 Industry segmentation
  • FIG. 2 Global kidney stones management market, 2014 - 2025 (USD Million)
  • FIG. 3 Industry ecosystem
  • FIG. 4 Distribution channel analysis
  • FIG. 5 Growth potential analysis, by type
  • FIG. 6 Growth potential analysis, by diagnostics
  • FIG. 7 Growth potential analysis, by treatment
  • FIG. 8 Porter's analysis
  • FIG. 9 PESTEL analysis